Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Cruciani

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Drug Discovery Today. Technologies|September 21, 2013
Metabolites: structure determination and predictionGabriele Cruciani
Drug Discovery Today|January 20, 2009
Molecular fields in drug discovery: getting old or reaching maturity?Simon Cross, Gabriele Cruciani
Journal of Chemical Information and Modeling|February 4, 2022
FragExplorer: GRID-Based Fragment Growing and ReplacementSimon Cross, Gabriele Cruciani
Journal of Chemical Information and Modeling|August 28, 2023
DeepGRID: Deep Learning Using GRID Descriptors for BBB PredictionLoriano Storchi, Gabriele Cruciani, Simon Cross
Journal of Medicinal Chemistry|May 30, 2003
Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9Ismael Zamora, Lovisa Afzelius, Gabriele Cruciani
Proteins|February 26, 2009
Predicting protein pK(a) by environment similarityFrancesca Milletti, Loriano Storchi, Gabriele Cruciani
Journal of Medicinal Chemistry|June 14, 2002
Suitability of molecular descriptors for database mining. A comparative analysisGabriele Cruciani, Manuel Pastor, Raimund Mannhold
Journal of Medicinal Chemistry|June 25, 2005
Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonistsGiuliano Berellini, Gabriele Cruciani, Raimund Mannhold
Journal of Medicinal Chemistry|October 1, 2004
Hydrogen bonding interactions of covalently bonded fluorine atoms: from crystallographic data to a new angular function in the GRID force fieldEmanuele Carosati, Simone Sciabola, Gabriele Cruciani
Expert Opinion on Drug Metabolism & Toxicology|September 16, 2014
Some considerations on the predictions of pharmacokinetic alterations in subjects with liver diseaseMartha Gonzalez, Laura Goracci, Gabriele Cruciani, et al.
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Drug Discovery Today. Technologies|September 21, 2013
Metabolites: structure determination and predictionGabriele Cruciani
Drug Discovery Today|January 20, 2009
Molecular fields in drug discovery: getting old or reaching maturity?Simon Cross, Gabriele Cruciani
Journal of Chemical Information and Modeling|February 4, 2022
FragExplorer: GRID-Based Fragment Growing and ReplacementSimon Cross, Gabriele Cruciani
Journal of Chemical Information and Modeling|August 28, 2023
DeepGRID: Deep Learning Using GRID Descriptors for BBB PredictionLoriano Storchi, Gabriele Cruciani, Simon Cross
Journal of Medicinal Chemistry|May 30, 2003
Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9Ismael Zamora, Lovisa Afzelius, Gabriele Cruciani
Proteins|February 26, 2009
Predicting protein pK(a) by environment similarityFrancesca Milletti, Loriano Storchi, Gabriele Cruciani
Journal of Medicinal Chemistry|June 14, 2002
Suitability of molecular descriptors for database mining. A comparative analysisGabriele Cruciani, Manuel Pastor, Raimund Mannhold
Journal of Medicinal Chemistry|June 25, 2005
Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonistsGiuliano Berellini, Gabriele Cruciani, Raimund Mannhold
Journal of Medicinal Chemistry|October 1, 2004
Hydrogen bonding interactions of covalently bonded fluorine atoms: from crystallographic data to a new angular function in the GRID force fieldEmanuele Carosati, Simone Sciabola, Gabriele Cruciani
Expert Opinion on Drug Metabolism & Toxicology|September 16, 2014
Some considerations on the predictions of pharmacokinetic alterations in subjects with liver diseaseMartha Gonzalez, Laura Goracci, Gabriele Cruciani, et al.
Pageof 16